<div id="readability-page-1">10:43 AM EST, 01/12/2026 (MT Newswires) -- (Updated headline and first paragraph)The French finance ministry said that Eli Lilly ( LLY ) has not contacted them about a potential bid to acquire Abivax ( ABVX ), which is compulsory for pharmaceutical companies under the country's investment screening rules, Bloomberg reported Monday.Abivax ( ABVX ) shares were up nearly 32% in recent premarket activity Monday after French media outlet La Lettre reported that Eli Lilly ( LLY ) was preparing a 15-billion-euro ($17.53 billion) takeover offer for the biotech startup.Before submitting a formal offer to Abivax's ( ABVX ) board, Lilly is waiting for a confirmation from France's finance ministry on whether the potential takeover would be subject to local foreign investment controls, according to a Google-translated text of the article.Abivax ( ABVX ) and Lilly didn't immediately respond to MT Newswires' requests for comment.Price: 1072.51, Change: +8.95, Percent Change: +0.84 MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

禮來

ABVX

法國財政部表示，禮來尚未就收購 Abivax 事宜與他們聯繫，而根據當地投資審查規則，這是必需的。在有關禮來可能提出 150 億歐元收購要約的報道後，Abivax 的股價上漲了近 32%。在正式提出要約之前，禮來正在等待財政部確認此次收購是否會受到外資投資管制的限制

更新：法國政府稱禮來公司未就收購 Abivax 進行任何聯繫